|
| Press Releases |
|
 |
|
| Friday, August 18, 2023 |
|
|
Champion REIT Announces 2023 Interim Results |
| Champion Real Estate Investment Trust (stock code: 2778), the owner of Three Garden Road and Langham Place, announces its financial results for the six months ended 30 June 2023. more info >> |
|
| Wednesday, July 19, 2023 |
|
|
冠君产业信托举办首届「环境、社会及管治论坛」 |
| 持有花园道三号及朗豪坊物业的冠君产业信托（「冠君产业信托」或「信托」）（股份代号：2778）举办以「倡导共享价值 携手坚韧前行」为主题的首届「环境、社会及管治(ESG)论坛」，标志着信托在实现净零排放及可持续发展过程中的一个重要里程碑。 more info >> |
|
|
冠君產業信託舉辦首屆「環境、社會及管治論壇」 |
| 持有花園道三號及朗豪坊物業的冠君產業信託（「冠君產業信託」或「信託」）（股份代號：2778）舉辦以「倡導共享價值 攜手堅韌前行」為主題的首屆「環境、社會及管治(ESG)論壇」，標誌著信託在實現淨零排放及可持續發展過程中的一個重要里程碑。 more info >> |
|
|
Champion REIT Hosts Inaugural ESG Forum |
| Champion Real Estate Investment Trust ("Champion REIT" or the "Trust") (Stock Code: 2778), owner of Three Garden Road and Langham Place, hosted its inaugural ESG Forum, with the theme "Championing Shared Values and Greater Resilience", marking an important milestone in the Trust's Net Zero and sustainability journey. more info >> |
|
| Monday, April 3, 2023 |
|
|
冠君及旗下朗豪坊商场举办「1+1捐赠LP CLUB积分」慈善活动 |
| 持有花园道三号及朗豪坊物业的冠君产业信托（「冠君产业信托」或「信托」）（股份代号：2778）与朗豪坊商场（「商场」）和两间本地非牟利组织「惜食堂」及「香港拯救猫狗协会」合作，于商场举办「1+1捐赠LP CLUB积分」慈善活动，共同为社会创造共享价值。 more info >> |
|
|
冠君及旗下朗豪坊商場舉辦「1+1捐贈LP CLUB積分」慈善活動 |
| 持有花園道三號及朗豪坊物業的冠君產業信託（「冠君產業信託」或「信託」）（股份代號：2778）與朗豪坊商場（「商場」）和兩間本地非牟利組織「惜食堂」及「香港拯救貓狗協會」合作，於商場舉辦「1+1捐贈LP CLUB積分」慈善活動，共同為社會創造共享價值。 more info >> |
|
|
Champion REIT and Langham Place Mall organise "1+1 LP CLUB Bonus Points Donation" campaign |
| Champion Real Estate Investment Trust ("Champion REIT" or "Trust") (Stock Code: 2778), owner of Three Garden Road and Langham Place, announced that Langham Place Mall ("the Mall") has cooperated with two local non-profit organizations, namely Food Angel and HK Saving Cat and Dog Association ("HKSCDA"), in organizing the "1+1 LP CLUB Bonus Points Donation" charity event for creating shared values and contribute to society. more info >> |
|
| Friday, February 24, 2023 |
|
|
冠君产业信托公布2022年度全年业绩 |
| 持有花园道三号及朗豪坊物业的冠君产业信托（股份代号：2778）公布2022年度全年业绩。 more info >> |
|
|
冠君產業信託公布2022年度全年業績 |
| 持有花園道三號及朗豪坊物業的冠君產業信託（股份代號：2778）公布2022年度全年業績。 more info >> |
|
|
Champion REIT Announces 2022 Annual Results |
| Champion Real Estate Investment Trust (stock code: 2778), the owner of Three Garden Road and Langham Place, announces its financial results for year ended 31 December 2022. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
維昇藥業（2561.HK）維臻高(R)獲批：重長效生長激素王者登場 重構百億市場的商業天花板
Feb 25, 2026 14:58 HKT/SGT
|
|
|
Hong Kong Tech Delegation Heading for Market Expansion at Mobile World Congress 2026
Feb 25, 2026 14:54 HKT/SGT
|
|
|
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
Feb 25, 2026 12:46 HKT/SGT
|
|
|
ベイシアのスーパーマーケット内の冷蔵・冷凍庫の温度点検・記録業務を富士通のIoT可視化ソリューションにより自動化
Feb 25, 2026 12:00: JST
|
|
|
Beisia Automates Supermarket Refrigerator Temperature Monitoring and Recording with Fujitsu's IoT Visualization Solution
Feb 25, 2026 12:00 JST
|
|
|
國泰君安國際獲批使用SIMM 衍生品風險管理接軌國際標準
Feb 25, 2026 10:34 HKT/SGT
|
|
|
国泰君安国际获批使用SIMM 衍生品风险管理接轨国际标准
Feb 25, 2026 10:34 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 22:30: JST
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT/SGT
|
|
|
TANAKA to Provide Medals for the Tokyo Marathon 2026 That Represent All the Participants in the Event with Woven Lines
Feb 24, 2026 22:00 JST
|
|
|
康哲藥業（867.HK/8A8.SG）：創新藥磷酸蘆可替尼乳膏增加特應性皮炎（AD）適應症中國上市許可申請獲受理並獲納入優先審評
Feb 24, 2026 20:31 HKT/SGT
|
|
|
康哲药业（867.HK/8A8.SG）：创新药磷酸芦可替尼乳膏增加特应性皮炎（AD）适应症中国上市许可申请获受理并获纳入优先审评
Feb 24, 2026 20:19 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Ships First Units of Systems for Marine Ammonia-Fueled Engines
Feb 24, 2026 20:07 JST
|
|
|
MHI Unveils "DIAVAULT," a Secure, High Performance Edge Data Center Platform
Feb 24, 2026 19:55 JST
|
|
|
康希諾生物曼海欣(R)擴齡正式獲批 為公司長期價值開啟更廣闊發展空間
Feb 24, 2026 18:15 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
